Chen et al. observed a reduction in BrdU+ cell numbers in young mice and high mortality rates when administering a daily 0.010 mg/kg dose of the synthetic cannabinoid HU210 to a transgenic Alzheimer's disease mouse model, forcing the researchers to halve the treatment duration.

Authors

• Person: Not available Organization: Springer
  Effects of psychedelics on neurogenesis and broader neuroplasticity

Sources

• Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Springer via serper

Referenced by nodes (1)

• Alzheimer's disease concept